Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHRISTEN F KUTZ

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical

NPI
1629138813
CMS profile
10683993
Location
COLORADO SPRINGS, CO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$105,437.54

336 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Page 6 of 7; records 251–300 of 336 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHRISTEN F KUTZ

NPI 1629138813 · CMS profile ID 10683993

Physician Assistants & Advanced Practice Nursing Providers / Physician Assistant / Medical

COLORADO SPRINGS, CO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 6 of 7; records 251–300 of 336 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1629138813?year=2022&recipient=provider&page=6#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHRISTEN F KUTZ, NPI 1629138813, CMS profile ID 10683993. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 6 of 7; records 251–300 of 336 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1629138813?year=2022&recipient=provider&page=6#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). CHRISTEN F KUTZ, NPI 1629138813, CMS profile ID 10683993. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 6 of 7; records 251–300 of 336 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1629138813?year=2022&recipient=provider&page=6#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
CHRISTEN F KUTZ, NPI 1629138813, CMS profile ID 10683993, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 6 of 7; records 251–300 of 336 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1629138813?year=2022&recipient=provider&page=6#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

336 matching records · $105,437.54 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 336 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 251–300 of 336.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
E.R. Squibb & Sons, L.L.C. $1,270.0004/13/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932499047 CMS
Celgene Corporation $8.5704/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932499039 CMS
Novartis Pharmaceuticals Corporation $12.3604/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894629567 CMS
Alexion Pharmaceuticals, Inc. $460.0004/07/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915664289 CMS
Biogen, Inc. $21.5804/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923393611 CMS
Biohaven Pharmaceutical Holding Company Ltd. $27.2304/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923874371 CMS
Acorda Therapeutics, Inc $24.6004/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920339401 CMS
E.R. Squibb & Sons, L.L.C. $79.0003/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932499043 CMS
Genentech USA, Inc. $24.8203/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950678943 CMS
Lilly USA, LLC $18.1103/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918408327 CMS
Alexion Pharmaceuticals, Inc. $287.5003/29/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914845775 CMS
EMD Serono, Inc. $140.0003/29/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941502741 CMS
LivaNova USA, Inc. $24.6703/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942200071 CMS
GENZYME CORPORATION $23.1703/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938890031 CMS
MDD US Operations, LLC $24.0303/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951621811 CMS
Alexion Pharmaceuticals, Inc. $230.0003/22/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915613105 CMS
Biogen, Inc. $16.6703/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923410969 CMS
E.R. Squibb & Sons, L.L.C. $1,270.0003/16/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932499037 CMS
Biogen, Inc. $12.1603/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923418867 CMS
EMD Serono, Inc. $140.0003/15/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941500765 CMS
Genentech USA, Inc. $23.6003/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950789581 CMS
Neurelis, Inc. $17.9103/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950165983 CMS
EMD Serono, Inc. $29.4103/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941499699 CMS
EMD Serono, Inc. $253.4903/12/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941499861 CMS
EMD Serono, Inc. $73.5303/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941500017 CMS
EMD Serono, Inc. $29.4103/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941500059 CMS
EMD Serono, Inc. $92.1103/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941500335 CMS
Banner Life Sciences, LLC $22.1503/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957718147 CMS
EMD Serono, Inc. $22.2703/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941499457 CMS
Neurocrine Biosciences, Inc. $18.6203/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963314329 CMS
Alexion Pharmaceuticals, Inc. $920.0003/08/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915396431 CMS
Celgene Corporation $10.8303/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932499033 CMS
MITSUBISHI TANABE PHARMA AMERICA, INC. $18.8103/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940566687 CMS
Biogen, Inc. $2,800.0003/03/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923394951 CMS
Biogen, Inc. $32.6303/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923396225 CMS
Biogen, Inc. $11.7003/03/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923416219 CMS
SK Life Science, Inc. $28.5203/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940684727 CMS
Biohaven Pharmaceutical Holding Company Ltd. $21.6802/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923874369 CMS
Abbott Laboratories $20.2902/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 921912745 CMS
ABBVIE INC. $5.8902/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892132183 CMS
Avanir Pharmaceuticals, Inc. $22.7302/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 935926569 CMS
Amgen Inc. $31.5602/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965585529 CMS
EISAI INC. $23.4002/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908109787 CMS
Biohaven Pharmaceutical Holding Company Ltd. $19.5402/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923874367 CMS
Celgene Corporation $13.6402/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932499031 CMS
GRT US Holding, Inc. $4.3602/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894634575 CMS
ABBVIE INC. $5.1802/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892132181 CMS
ABBVIE INC. $2,345.0002/14/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892132175 CMS
ABBVIE INC. $140.4002/14/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892132177 CMS
ABBVIE INC. $14.4202/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892132179 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $111,641.13 346
PY2022 $105,437.54 336
PY2023 $92,596.59 345
PY2024 $108,320.18 352
PY2025 $191,690.32 460

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $569,506.58 27
PY2024 Principal investigator $482,223.27 25
PY2023 Recipient $19,775.00 3
PY2023 Principal investigator $296,655.49 43
PY2022 Principal investigator $140,946.40 16
PY2021 Recipient $5,814.59 2
PY2021 Principal investigator $290,542.63 24

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

27 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 TG Therapeutics, Inc. $75.00 12/23/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200902
Principal investigator 1 TG Therapeutics, Inc. $100.00 12/11/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200900
Principal investigator 1 TG Therapeutics, Inc. $50.00 12/03/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200898
Principal investigator 1 TG Therapeutics, Inc. $5,840.00 11/30/2025 Non-covered Recipient Entity
Research of the Rockies, LLC
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200405
Principal investigator 1 TG Therapeutics, Inc. $43,975.00 11/30/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200888
Principal investigator 1 TG Therapeutics, Inc. $50.00 11/18/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200896
Principal investigator 1 TG Therapeutics, Inc. $100.00 11/06/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200894
Principal investigator 1 TG Therapeutics, Inc. $23,750.00 11/01/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200886
Principal investigator 1 TG Therapeutics, Inc. $100.00 10/23/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200892
Principal investigator 1 TG Therapeutics, Inc. $125.00 10/07/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200890
Principal investigator 1 TG Therapeutics, Inc. $41,550.00 10/01/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200882
Principal investigator 1 TG Therapeutics, Inc. $34,975.00 10/01/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200884
Principal investigator 1 TG Therapeutics, Inc. $41,550.00 09/30/2025 Non-covered Recipient Entity
Research Center of Southern CaliforniaLLC
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200403
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $24,242.00 09/27/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN RESEARCH AND CONSULTING
Retrospective analysis of Intravenous immunoglobulin (IVIG) infusion switches to immune globulin infusion 10% with recombinant human hyaluronidase in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) No dispute reported 06/30/2026 1223286005
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $11,000.00 09/26/2025 Non-covered Recipient Entity
Research Of The Rockies
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Agitation Associated with Alzheimers Disease No dispute reported 06/30/2026 1235994249
Principal investigator 1 TG Therapeutics, Inc. $34,975.00 08/31/2025 Non-covered Recipient Entity
Research Center of Southern CaliforniaLLC
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200401
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $24,242.00 08/09/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN RESEARCH AND CONSULTING
Retrospective analysis of Intravenous immunoglobulin (IVIG) infusion switches to immune globulin infusion 10% with recombinant human hyaluronidase in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) No dispute reported 06/30/2026 1223283989
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $93,350.00 07/18/2025 Non-covered Recipient Entity
Rocky Mountain Research And Consulting
Retrospective analysis of RW treatment with KarXT in schizophrenia No dispute reported 06/30/2026 1235994151
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $1,122.70 06/25/2025 Non-covered Recipient Entity
Colorado Springs Neurological Associates, PC
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Agitation Associated with Alzheimers Disease No dispute reported 06/30/2026 1235997920
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $24,242.00 05/15/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN RESEARCH AND CONSULTING
Retrospective analysis of Intravenous immunoglobulin (IVIG) infusion switches to immune globulin infusion 10% with recombinant human hyaluronidase in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) No dispute reported 06/30/2026 1223279852
Principal investigator 1 Eli Lilly and Company $388.00 04/01/2025 Non-covered Recipient Entity
COLORADO SPRINGS NEUROLOGICAL ASSOCIATES
PREVENTIVE TREATMENT OF MIGRAINE: OUTCOMES FOR PATIENTS IN REAL-WORLD HEALTHCARE SYSTEMS (TRIUMPH) No dispute reported 06/30/2026 1187880119
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $145,100.00 02/03/2025 Non-covered Recipient Entity
Rocky Mountain Research And Consulting
Retrospective analysis of the efficacy, safety, and tolerability outcomes after CD20-directed cytolytic antibody treatment switches to ozanimod in patients with relapsing multiple sclerosis (MS) No dispute reported 06/30/2026 1235994149
Principal investigator 1 Roche Products Limited $285.24 01/09/2025 Non-covered Recipient Entity
COLORADO SPRINGS NEUROLOGICAL ASSOCIATES PC
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211590064
Principal investigator 1 Roche Products Limited $171.16 01/09/2025 Non-covered Recipient Entity
COLORADO SPRINGS NEUROLOGICAL ASSOCIATES PC
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211590069
Principal investigator 1 Roche Products Limited $285.24 01/09/2025 Non-covered Recipient Entity
COLORADO SPRINGS NEUROLOGICAL ASSOCIATES PC
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211590072
Principal investigator 1 Roche Products Limited $285.24 01/09/2025 Non-covered Recipient Entity
COLORADO SPRINGS NEUROLOGICAL ASSOCIATES PC
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211590077
Principal investigator 1 Eli Lilly and Company $17,578.00 01/07/2025 Non-covered Recipient Entity
COLORADO SPRINGS NEUROLOGICAL ASSOCIATES
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE No dispute reported 06/30/2026 1187878597